Home>Valeant Pharmaceuticals International VRX Q1 2011 Earnings Call Transcript
Valeant Pharmaceuticals International VRX Q1 2011 Earnings Call Transcript
Earnings Call Transcripts by Morningstar Inc.
Mon, 9 May 2011
Good morning. My name is Sara and I will be your conference operator today. At this time, I would like to welcome everyone to the Valeant Pharmaceuticals First Quarter 2011 Results Conference Call. All lines have been placed on mute to prevent any
Morningstar director of economic analysis Bob Johnson addresses recent sluggishness in the economy and makes the case for better growth in the second half of the year.
Homebuilder sentiment, start and permit trends, and consumer behavior suggest a turn for the long-suffering housing market, says Morningstar's Bob Johnson.